Lexicon Pharmaceuticals
Clinical trials sponsored by Lexicon Pharmaceuticals, explained in plain language.
-
New drug aims to ease lingering shingles nerve pain
Symptom relief CompletedThis study tested an experimental drug called LX9211 to see if it can reduce pain caused by postherpetic neuralgia, a nerve pain that continues after a shingles rash heals. The trial involved 79 adults with moderate to severe pain lasting at least 3 months. Participants received …
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 11:35 UTC
-
New pill aims to calm burning nerve pain in diabetes
Symptom relief CompletedThis study tested an experimental drug called LX9211 to see if it can reduce pain caused by nerve damage from diabetes. About 496 adults with diabetic nerve pain took either the drug or a placebo for 8 weeks. The main goal was to see if the drug lowers average daily pain scores b…
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC